News

The Manila Times1d
ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025
Key results from the interim analysis of the Phase 3 ENLIGHTED study of Padeliporfin VTP: As of November 5, 2024, the data ...
Menopause drug Duavee may help prevent invasive breast cancer, clinical trial finds
A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new ...
University of California, San Francisco2d
Predictive Biomarkers, Tailored Therapy Among Conference Presentations
Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...
ascopubs.org4d
Characterisation of ductal carcinoma in situ (DCIS) using mass spectrometry imaging towards near realtime margin assessment.
Multi-omics cohort-based prediction model for early relapse of hepatocellular carcinoma post-surgery. IDeate-PanTumor02: A phase 1b/2 study to evaluate the efficacy and safety of ifinatamab deruxtecan ...
The Lancet3d
Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features
aDivision of Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands ...